Hungarian Covid Drug Prevents Serious Illness In Animal Trials

  • 27 Jan 2021 9:32 AM
  • Hungary Matters
Hungarian Covid Drug Prevents Serious Illness In Animal Trials
It appears that a drug which mimics antibodies being developed in Hungary is effective in preventing serious complications arising from Covid-19, a scientist at Budapest’s Eötvös Loránd University said, reporting on tests carried out on animals.

Imre Kacskovics, an immunologist who heads the university’s science faculty, told public broadcaster Kossuth Rádió that a team from pharmaceutical firm Richter Gedeon has managed to produce the compound which was formulated last March.

The drug is designed to make the body resistant 12 hours after the jab.

The animal experiments conducted so far show that hamsters infected with the coronavirus do not develop severe symptoms after being administered the drug.

Human clinical trials are scheduled to be carried out in the late autumn after a sequence of further tests.

Kacskovics said the drug was preventative rather than curative and should be used in the early stages of infection.

Photo courtesy: Eötvös Loránd University

  • How does this content make you feel?

XpatLoop Media Partner

Hungary Matters

Launched in January 2014, this twice-daily newsletter covers 'everything you need to know about what’s going on in Hungary and beyond', according to its publisher the state media agency MTI. Click the title above for more info, and to subscribe.

Explore More Reports